EyePoint Pharmaceuticals Inc. (EYPT)

Business: EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom.

IPO Date: 27-Jan-2005

Pres, CEO & Director: Ms. Nancy S. Lurker

Chief Financial Officer: Mr. George O. Elston

Listing: NASDAQ: EYPT

Country: United States

Headquarters: Watertown, MA

Website: https://eyepointpharma.com

Market cap: $246.84 Mln

Revenue (TTM): $38.91 Mln

Earnings (TTM): $-67.11 Mln

Cash: $190.78 Mln

Total Debt: $41.28 Mln

Insider's Holding: 11.71%

Liquidity: Low

52 Week range: $7.00 - 21.50

Shares outstanding: 34,047,100

10 Years Aggregate:

• CFO: $-198.06 Mln
• EBITDA: $-262.46 Mln
• Net Profit: $-297.55 Mln